Chloramphenicol hemisuccinate

Chloramphenicol hemisuccinate Structure
CAS No.
3544-94-3
Chemical Name:
Chloramphenicol hemisuccinate
Synonyms
Chronicin foam;Paraxin succinate;Kemicetine succinate;Levomycetin succinate;Chloromycetin succinate;Chloramphenicol succinate;Levomycetin hemisuccinate;Chloramphenicol 3-succinate;Chloramphenicol hemisuccinate;Chloramphenicol monosuccinate
CBNumber:
CB2925965
Molecular Formula:
C15H16Cl2N2O8
Molecular Weight:
423.2
MOL File:
3544-94-3.mol
Modify Date:
2023/6/8 9:02:56

Chloramphenicol hemisuccinate Properties

Melting point 127 °C
Boiling point 716.3±60.0 °C(Predicted)
Density 1.6769 (rough estimate)
refractive index 1.7350 (estimate)
storage temp. Store at -20°C
solubility DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
form A solid
pka 4.36±0.17(Predicted)

SAFETY

Risk and Safety Statements

Chloramphenicol hemisuccinate Chemical Properties,Uses,Production

Description

Chloramphenicol succinate is a water-soluble prodrug form of the antibiotic chloramphenicol. It is a substrate for succinate dehydrogenase (SDH) and is oxidized by human liver and rat liver and kidney mitochondria to release chloramphenicol in vitro. Chloramphenicol succinate reduces human leukocyte migration in vitro. In vivo, chloramphenicol succinate reduces E. coli growth in rabbit and rat models of pyelonephritis when administered at doses of 150 and 200 mg/kg, respectively. Chloramphenicol succinate (20 mg/kg) reduces infarct size in a porcine model of myocardial ischemia-reperfusion injury. Formulations containing chloramphenicol succinate have been used in the treatment of severe bacterial infections.

Uses

Chloramphenicol succinate is prepared by acylation of chloramphenicol with succinic anhydride to provide a water soluble pro-drug. Chloramphenicol succinate represents an alternative pro-drug strategy for chloramphenicol that has found a niche in surface antibiotic treatment in surgery. Chloramphenicol succinate is significantly less active than chloramphenicol but acts as a prodrug, forming chloramphenicol in the presence of succinate dehydrogenase.

Chloramphenicol hemisuccinate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 39)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ShreeGen Pharma Ltd (part of Rumit Group of Companies) +91-4023869399 +91-9664830616 Telangana, India 25 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Nabros Pharma Private Limited 08048372725Ext 851 Ahmedabad, India 2 58 Inquiry
Cardkem Pharma Pvt Ltd 08048361295Ext 942 Gujarat, India 14 58 Inquiry
Noblemeds And Surgicals Private Limited 08048988975 Nagpur, India 12 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Hefei TNJ Chemical Industry Co.,Ltd. 0551-65418671 China 34571 58 Inquiry
AFINE CHEMICALS LIMITED +86-0571-85134551 China 15395 58 Inquiry
BOC Sciences 16314854226; +16314854226 United States 19743 58 Inquiry
[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hydrogen [R-(R*,R*)]-succinate Butanedioic acid hydrogen 1-[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester Chloramphenicol 3-succinate Succinic acid hydrogen 1-[(2R,3R)-3-(4-nitrophenyl)-2-(dichloroacetylamino)-3-hydroxypropan-1-yl] ester ChloraMphenicol succinate, KeMicetine Chloramphenicol succinate Acetamide, 2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl]-, α-(hydrogen succinate), D-(-)-threo- (8CI) Butanedioic acid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester Butanedioic acid, mono[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester, [R-(R*,R*)]- Chloramphenicol 3-monosuccinate Chloramphenicol acid succinate Chloramphenicol hemisuccinate Chloramphenicol hydrogen succinate Chloramphenicol monosuccinate Chloromycetin succinate Chronicin foam Kemicetine succinate Levomycetin hemisuccinate Levomycetin succinate Paraxin succinate Succinic acid, ester with chloramphenicol (6CI) Succinic acid, α-monoester with D-threo-(-)-2,2-dichloro-N-[β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl]acetamide (8CI) 4-[2-[(2,2-Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid 4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoicaci 3544-94-3 C15H16Cl2N2O8